Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ABL1 |
Variant | G321L |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | ABL1 G321L (corresponding to G340L in isoform IB) lies within the protein kinase domain of the Abl1 protein (UniProt.org). G321L does not result in increased phosphorylation of Crkl by Abl1, but leads to increased cytoplasmic Abl1 retention and is associated with increased cell survival in culture (PMID: 26758680), and therefore, is predicted to lead to a gain of Abl1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ABL1 mutant ABL1 act mut ABL1 G321L |
Transcript | NM_005157.6 |
gDNA | chr9:g.130872913_130872914delGGinsCT |
cDNA | c.961_962delGGinsCT |
Protein | p.G321L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005157 | chr9:g.130872913_130872914delGGinsCT | c.961_962delGGinsCT | p.G321L | RefSeq | GRCh38/hg38 |
NM_005157.6 | chr9:g.130872913_130872914delGGinsCT | c.961_962delGGinsCT | p.G321L | RefSeq | GRCh38/hg38 |
NM_005157.5 | chr9:g.130872913_130872914delGGinsCT | c.961_962delGGinsCT | p.G321L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|